CLINICAL_TRIALS
trial_result
· 2020-08-12
Clinical Trial Update: Dasotraline Binge Eating Disorder Extension Study [Phase 3]
Summary
Phase 3 extension study update for dasotraline in binge eating disorder; trial completed with results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sumitomo Pharma America, Inc. | Conditions: Binge Eating Disorder | Phase 3 | Status: COMPLETED | Results posted: 2020-08-12